PT1047446E - Composicao vacinica para o virus herpes simplex e metodos de utilizacao - Google Patents

Composicao vacinica para o virus herpes simplex e metodos de utilizacao

Info

Publication number
PT1047446E
PT1047446E PT99902294T PT99902294T PT1047446E PT 1047446 E PT1047446 E PT 1047446E PT 99902294 T PT99902294 T PT 99902294T PT 99902294 T PT99902294 T PT 99902294T PT 1047446 E PT1047446 E PT 1047446E
Authority
PT
Portugal
Prior art keywords
methods
herpes simplex
vaccine composition
simplex virus
virus
Prior art date
Application number
PT99902294T
Other languages
English (en)
Inventor
Laure Aurelian
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland filed Critical Univ Maryland
Publication of PT1047446E publication Critical patent/PT1047446E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
PT99902294T 1998-01-16 1999-01-15 Composicao vacinica para o virus herpes simplex e metodos de utilizacao PT1047446E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/008,388 US6054131A (en) 1998-01-16 1998-01-16 Vaccine composition for herpes simplex virus and method of using

Publications (1)

Publication Number Publication Date
PT1047446E true PT1047446E (pt) 2004-04-30

Family

ID=21731361

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99902294T PT1047446E (pt) 1998-01-16 1999-01-15 Composicao vacinica para o virus herpes simplex e metodos de utilizacao

Country Status (11)

Country Link
US (2) US6054131A (pt)
EP (1) EP1047446B1 (pt)
JP (1) JP2002509113A (pt)
AT (1) ATE254474T1 (pt)
AU (1) AU742281B2 (pt)
CA (1) CA2318439A1 (pt)
DE (1) DE69912925T2 (pt)
DK (1) DK1047446T3 (pt)
ES (1) ES2212521T3 (pt)
PT (1) PT1047446E (pt)
WO (1) WO1999036084A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344839B2 (en) * 2004-12-23 2008-03-18 Aurx, Inc. Virus preparations and methods
US20060141483A1 (en) * 2004-12-23 2006-06-29 Calton Gary J Stabilization of viral compositions
EP1916298B1 (en) * 2005-06-14 2011-12-28 Dnavec Corporation Methods for producing monoclonal antibodies
CN101495126B (zh) * 2005-06-23 2016-01-06 休斯顿大学 Ⅱ型单纯疱疹病毒突变体在治疗癌症中的用途
US20070122344A1 (en) 2005-09-02 2007-05-31 University Of Rochester Medical Center Office Of Technology Transfer Intraoperative determination of nerve location
WO2007097820A2 (en) * 2005-11-18 2007-08-30 The Ohio State University Research Foundation Viral gene products and methods for vaccination to prevent viral associated diseases
US7790203B2 (en) * 2005-12-13 2010-09-07 Lowder Tom R Composition and regimen for the treatment of herpes simplex virus, herpes zoster, and herpes genitalia epidermal herpetic lesions
JP5571380B2 (ja) * 2006-07-24 2014-08-13 ルミナス バイオサイエンシズ，インコーポレイテッド オストワルド熟成を減少させた水不溶性の医薬品物質の固体ナノ粒子処方物
US20080161744A1 (en) 2006-09-07 2008-07-03 University Of Rochester Medical Center Pre-And Intra-Operative Localization of Penile Sentinel Nodes
US8406860B2 (en) 2008-01-25 2013-03-26 Novadaq Technologies Inc. Method for evaluating blush in myocardial tissue
US10219742B2 (en) 2008-04-14 2019-03-05 Novadaq Technologies ULC Locating and analyzing perforator flaps for plastic and reconstructive surgery
WO2009135178A2 (en) 2008-05-02 2009-11-05 Flower Robert W Methods for production and use of substance-loaded erythrocytes (s-les) for observation and treatment of microvascular hemodynamics
CN102026668A (zh) 2008-05-14 2011-04-20 诺瓦达克技术公司 用于神经成像的包括与病毒组分结合的荧光染料的成像法和组合物
US10492671B2 (en) 2009-05-08 2019-12-03 Novadaq Technologies ULC Near infra red fluorescence imaging for visualization of blood vessels during endoscopic harvest
RU2585961C9 (ru) 2009-05-22 2016-12-27 Дженосеа Биосайенсиз Инк. Вакцины против вируса простого герпеса 2 типа: композиции и способы запуска иммунного ответа
US9782474B2 (en) 2010-11-24 2017-10-10 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
JP6199878B2 (ja) 2011-11-23 2017-09-20 ジェノセア バイオサイエンシーズ， インコーポレイテッド 単純ヘルペスウイルス２型に対する核酸ワクチン：免疫応答を誘発する組成物及び方法
CA2914778A1 (en) 2012-06-21 2013-12-27 Novadaq Technologies Inc. Quantification and analysis of angiography and perfusion
CA2963987A1 (en) 2014-09-29 2016-04-07 Novadaq Technologies Inc. Imaging a target fluorophore in a biological material in the presence of autofluorescence
KR101955134B1 (ko) 2014-10-09 2019-03-06 노바다크 테크놀러지즈 유엘씨 형광-조정 광전용적맥파 측정기를 사용한 조직 내의 절대적인 혈류의 정량화
JP2019537555A (ja) 2016-09-28 2019-12-26 ジェノセア バイオサイエンシーズ， インコーポレイテッド ヘルペスを処置するための方法および組成物
US11140305B2 (en) 2017-02-10 2021-10-05 Stryker European Operations Limited Open-field handheld fluorescence imaging systems and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
US4347127A (en) * 1981-01-29 1982-08-31 Gulf & Western Manufacturing Company Apparatus and method for froth flotation separation of the components of a slurry
US4554159A (en) * 1981-11-12 1985-11-19 Institute Merieux Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
US5219567A (en) * 1982-03-24 1993-06-15 The University Of Birmingham Vaccine against herpes viruses
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine

Also Published As

Publication number Publication date
DE69912925T2 (de) 2004-09-02
EP1047446A1 (en) 2000-11-02
AU2231299A (en) 1999-08-02
AU742281B2 (en) 2001-12-20
CA2318439A1 (en) 1999-07-22
EP1047446B1 (en) 2003-11-19
DE69912925D1 (de) 2003-12-24
ATE254474T1 (de) 2003-12-15
ES2212521T3 (es) 2004-07-16
JP2002509113A (ja) 2002-03-26
EP1047446A4 (en) 2001-12-19
DK1047446T3 (da) 2004-03-29
US6054131A (en) 2000-04-25
WO1999036084A1 (en) 1999-07-22
US6207168B1 (en) 2001-03-27

Similar Documents

Publication Publication Date Title
PT1047446E (pt) Composicao vacinica para o virus herpes simplex e metodos de utilizacao
ATE287728T1 (de) Adjuvierte rekombinante lebendimpfstoffe gegen influenza- oder herpesviren
IL141044A0 (en) Innunological herpes simplex virus antigens and methods for use thereof
HN1997000072A (es) Procedimiento para la preparacion de sildenafil
CY1105963T1 (el) Συνθεσεις καψομepιδιακου εμβολιου του ιου του θηλωματος και μεθοδοι χρησης
ES2186018T3 (es) Procedimiento para preparar tolterodina.
BR9710012B1 (pt) vacina veterinária viva recombinante e fórmula de vacina multivalente.
DE69800477D1 (de) Langhaltender Phosphor
BR9913761B1 (pt) uso de uma composiÇço para proteÇço de tecidos.
ID17860A (id) Komposisi vaksin
ES2177638T3 (es) Uso de mycobacterium para el tratamiento de tumores.
DK0939648T3 (da) Rotavirusvaccineformuleringer
AU1508699A (en) Live attenuated influenza vaccine
NO972228D0 (no) Nytt tumorsuppresor-gen, HIC-1
NO20002504L (no) Adenovirusvektorer og fremgangsmÕte for Õ redusere homologe rekombinasjonsfenomener
BR9712058B1 (pt) formulações para uso de ivermectina, processo para sua preparação e uso.
PT1053017E (pt) Vacinas compreendendo interleucina-12 e antigenio de virus herpes simplex
DE69817658D1 (de) Verfahren zur Staubeseitigung von Kopierblättern
ATE386049T1 (de) Epstein-barr virus type b ctl epitopen
DK1248650T3 (da) Forbedrede DNA-vacciner til bovint herpesvirus 1
IL143149A0 (en) Stable, attenuated rabies virus mutants and live vaccines thereof
EA200000112A1 (ru) Новая композиция
ATE295182T1 (de) Zusammensetzungen zur immunverstärkung von impfstoffen
MX9207264A (es) Compuestos de sulfonimidamida, procedimiento para su preparacion y formulaciones farmaceuticas que los contienen
BR9601207A (pt) Abaixador de língua para uso médico